12-month sales of AB Linas Agro Group went up 43%, net profit was 56% higher


Consolidated revenue of AB Linas Agro Group, the owner of agricultural and food industry companies, grew by 43% and amounted to EUR 942 million. Consolidated earnings before interest, taxes, depreciation and amortization (EBITDA) increased by 35% to EUR 35 million.

In the last twelve months ended June 30, the group of companies earned EUR 21 million operating profit or 43% more than in a previous year. Gross profit was EUR 52 million or 15% higher than in the previous year. Profit before taxes grew by 54% to EUR 18.4 million. Net profit increased by 56% to EUR 15.7 million.

AB Linas Agro Group companies sold 3.16 million tons of production or 41% more than a year before.

‘We have shown the best result in the last five years. Despite the unfavorable price changes in the markets, which affected some of our business segments, the overall result of the Group shows that we were able to take advantage of the opportunities provided by last season’s good harvest’, said Mažvydas Šileika, Finance Director of AB Linas Agro Group.

During the ended financial year, the Group sold a total of 2.3 million tons of grain and oilseeds, or 58% more than in the same period last year. Trade in feedstuff also increased by 10%. Total revenue from trade in grain, oilseeds, and feedstuff grew by 62% year-on-year to EUR 680 million, and the operating profit was 2% higher and equal to EUR 6.35 million.

‘The record harvest of 2020 in all the Baltic countries caused both joy and concern. Our elevator network in Lithuania and Latvia collected record quantities of grain - 58% more than a year before, or 661 thousand tons. We exceeded the projected capacity and had to store part of the grain in uncovered stations. Although the quantities of cereals purchased have increased, the increased price volatility in the market due to the COVID-19 pandemic, especially in the feedstuff segment, has not led to a stronger increase in operating profitability’, M. Šileika commented the performance results of the largest business segment of the Group.

The Group’s revenue from goods and services for farmers grew by 15% to EUR 180 million, and the operating profit was 149% higher and almost reached EUR 9 million. Sales of certified seeds went up 5%, plant care products and micronutrients sales increased by 25%, sales of fertilizers were 3% higher. Agricultural machinery sales went up more than 32%, revenue from spare parts sales and services increased by 20%. Grain preparation facilities and livestock farms installation projects generated 15% higher sales than a year before.

Good yields and efficient management helped to exploit the potential of agricultural companies: 103 thousand tons of crop production has been sold, which is 30% more than in the previous year, revenue went up 18% to EUR million, and operating profit was 80% higher than a year before and exceeded EUR 11 million.

‘We have closed the unprofitable milk production unit. Though the number of dairy cows decreased by almost 7%, efficient production management helped achieve good results - we sold as much milk as last year or 34 thousand tons,’ told M. Šileika.

The Group’s poultry companies operating in Latvia did not increase production: they produced and sold as much poultry meat as in the previous year. Thirty-two thousand tons of poultry and its products have been sold. However, revenue from this activity shrank by 3 % and amounted to EUR 72 million, and the operating result was EUR 0.9 million loss.

‘Although we saw an increase in chicken prices in the last quarter of the financial year, unfortunately, the prices of raw materials used for chicken fodder went up even earlier and faster, and their high prices sharply increased the production costs of poultry products. At the same time, wage and energy costs rose. Due to these reasons, the activities of the poultry segment have become unprofitable, ‘said M. Šileika.

About AB Linas Agro Group

AB Linas Agro Group is the largest agribusiness and food group in the Baltic States, the shares of which are traded on the Nasdaq Vilnius Stock Exchange.

In mid-July this year, Linas Agro Group completed one of the most significant business acquisitions: it acquired controlling stakes in AB Kauno Grūdai, AB Kaišiadorių Paukštynas, AB Vilniaus Paukštynas and related companies. The acquisition has been completed after the end of the reporting period.

At the time of publication of the announcement, Linas Agro Group owns 77 companies located in the Baltic States, Ukraine, Poland, Russia, and Belarus and employs over 5,600 people. The group of companies operates in the production and trade of agricultural and food products and supplies goods and services to farmers.

AB Linas Agro Group Consolidated unaudited Financial Statements and Interim Activity Report for the twelve months period ended 30 June 2021

Mažvydas Šileika, Finance Director of AB Linas Agro Group
Mob. +370 619 19 403


To view this piece of content from, please give your consent at the top of this page.
To view this piece of content from, please give your consent at the top of this page.

About GlobeNewswire

One Liberty Plaza - 165 Broadway
NY 10006 New York

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire

Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire

After safety review The Connection study is now again open to recruit the smallest infants.22.9.2021 22:30:00 CEST | Press release

After safety review The Connection study is now again open to recruit the smallest infants. Following the completion of the DMC (Data Monitoring Committee) safety review, IBT is pleased to announce the continuation of the recruitment of patients between 500 - 1000g (Strata A and B) in the Connection study. “Given the vulnerability of the Stratum A population, infants with a birth weight less than 750 gram, we have agreed with the FDA to carefully monitor the safety of these infants. Therefore, the independent DMC has completed an additional safety review, and there are no objections to continue the study. We expect recruitment to increase as we now again recruit in two strata. ” Says Staffan Strömberg, Chief Executive Officer of IBT. About Infant Bacterial Therapeutics AB Infant Bacterial Therapeutics AB (“IBT”) is a public company domiciled in Stockholm. The company’s Class B shares are listed on Nasdaq Stockholm, Mid-cap (IBT B). Infant Bacterial Therapeutics AB (publ) (“IBT”) is a p

Efter säkerhetsgranskning har rekryteringen av de minsta barnen i the Connection study återupptagits.22.9.2021 22:30:00 CEST | Pressemelding

Efter säkerhetsgranskning har rekryteringen av de minsta barnen i the Connection study återupptagits. Efter att säkerhetsgranskningen som utförts av Data Monitoring Committee (DMC) har slutförts kan IBT nu lämna det glädjande beskedet att rekryteringen av spädbarn i båda viktgrupperna, 500–1000 gram (Strata A och B), kan fortsätta. ”Med anledning av att spädbarnen i stratum A, som har en födelsevikt på mindre än 750 gram, är mycket känsliga har vi enats med FDA om att övervaka säkerheten för dessa spädbarn mycket noggrant. Den oberoende DMC har med anledning av detta slutfört en extra säkerhetsgranskning där det inte föreligger några invändningar mot att fortsätta studien. Vi förväntar oss att rekryteringstakten kommer att öka när vi återigen kan rekrytera i två strata. ” säger Staffan Strömberg, VD för IBT. Om Infant Bacterial Therapeutics AB Infant Bacterial Therapeutics AB (”IBT”) är ett publikt bolag med säte i Stockholm. Bolagets aktier av serie B handlas på Nasdaq Stockholm, Mid

Weekly share repurchase program transaction details22.9.2021 19:34:35 CEST | Press release

September 22, 2021 SBM Offshore reports the transaction details related to its EUR150 million (c. US$180 million) share repurchase program for the period September 16, 2021 through September 22, 2021. The repurchases were made under the EUR150 million share repurchase program announced on and effective from August 5, 2021. The objective of the program is to reduce share capital and, in addition, to provide shares for regular management and employee share programs. Information regarding the progress of the share repurchase program and the aggregate of the transactions (calculated on a daily basis) for the period August 5, 2021 through September 22, 2021 can be found in the top half of the table below. Further detailed information regarding both the progress of the share repurchase program and all individual transactions can be accessed via the Investors section of the Company’s website. Share Repurchase Program Overall progress Share Repurchase Program: Total Repurchase Amount EUR 150,0

21Shares Announces Listing of Six Additional Crypto ETPs on Deutsche Boerse XETRA22.9.2021 19:11:35 CEST | Press release

Firm is first and only to give investors access to 10 crypto listings in Germany September 22, 2021 – 21Shares AG (“21Shares”), the world’s largest issuer of cryptocurrency ETPs, today announced the listing of six additional cryptocurrency ETPs for a total of 10 on Deutsche Boerse XETRA, Germany’s top trading venue for exchange traded funds. The new crypto ETPs include Solana ETP (Ticker: 21XL GY), Polkadot ETP (Ticker: PDOT GY), Cardano ETP (Ticker: DADA GY), Stellar Lumens ETP (Ticker: XLME GY), Tezos (Ticker: 21XZ GY), and the Crypto Basket Index ETP (Ticker:21XH GY). Hany Rashwan, Co-Founder and CEO of 21Shares said, “We are pleased to expand crypto investment opportunities in Germany, as one of our key markets, where we are the first and only firm providing such a comprehensive product suite. This development underscores our commitment to helping investors safely access crypto assets, now and in the future.” The six Xetra-listed crypto ETPs emphasize 21Shares’ leadership in crypto

Regarding public information about Klaipeda Prosecutor Office civil claim concerning AB “Klaipedos nafta” shares granted to employees22.9.2021 18:03:11 CEST | Press release

Public sources of information provided that the Klaipeda Prosecutor Office has submitted a civil claim against AB "Klaipedos nafta" (KN) on a ground of protection of public interest. As suggested by the media, a civil claim is concerning shares granted to employees in 2019. KN granted the shares to employees in 2019 according to the Rules for granting shares, which were approved in the general shareholders meeting. Relevant link: KN has not received a civil claim, thus is unable to provide any comments on the issue. Chief Financial Officer Mindaugas Kvekšas, +370 614 82665

Touax: H1 2021 results22.9.2021 17:45:00 CEST | Press release

PRESS RELEASE Paris, 22 September 2021 – 5.45 p.m. YOUR OPERATIONAL LEASING SOLUTION FOR SUSTAINABLE TRANSPORTATION H1 2021 results Restated revenue from activities of €52.5 million, up €1.2 millionResilient business performance with EBITDA of €21.3 million and the Group share of net income amounting to €2.0 millionFavourable outlook with strong investments Touax Group continued to deliver a positive performance while the health crisis caused further disruption. Its results were stable against the same period in 2020, with the exception of sales fees, which declined but were partially offset by sales of owned equipment. The growth in the shipping container leasing business, driven by the shortage of containers, limited asset returns and therefore sales of used containers and sales fees. ANALYSIS OF H1 2021 REVENUE FROM ACTIVITIES The restated presentation of revenue from activities is as follows: Restated Revenue from activities (in € thousand)Q1 2021Q2 2021H1 2021Q1 2020Q2 2020H1 2020

Bolder Surgical announces global launch of the CoolSeal™ Vessel Sealing Platform22.9.2021 16:44:21 CEST | Press release

CoolSeal receives CE mark, Japan PMDA approval; now available in over 20 countries worldwide LOUISVILLE, COLORADO, Sept. 22, 2021 (GLOBE NEWSWIRE) -- Bolder Surgical today announced the global launch of its CoolSeal™ Vessel Sealing platform. CoolSeal has been in use since October 2020 in the U.S., and with the new international regulatory approvals the devices are available in over 20 countries around the world. Bolder Surgical provides surgeons precision electrosurgical instruments to perform minimally invasive surgery safely and effectively in pediatric and adult procedures including general, gynecological and bariatric surgical applications. The CoolSeal Vessel Sealing suite includes the 3 mm Mini (formerly JustRight Sealer) and the 5 mm Trinity Sealer/Divider/Dissector. Both devices are powered with the gold-standard efficacy of advanced bipolar RF vessel sealing technology. “Having successfully used the 3 mm vessel sealer for many cases in pediatric surgery, the Trinity 5 mm devic